Lutaf Islam

834 total citations · 1 hit paper
10 papers, 577 citations indexed

About

Lutaf Islam is a scholar working on Otorhinolaryngology, Physiology and Immunology and Allergy. According to data from OpenAlex, Lutaf Islam has authored 10 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Otorhinolaryngology, 5 papers in Physiology and 4 papers in Immunology and Allergy. Recurrent topics in Lutaf Islam's work include Sinusitis and nasal conditions (7 papers), Asthma and respiratory diseases (5 papers) and Allergic Rhinitis and Sensitization (4 papers). Lutaf Islam is often cited by papers focused on Sinusitis and nasal conditions (7 papers), Asthma and respiratory diseases (5 papers) and Allergic Rhinitis and Sensitization (4 papers). Lutaf Islam collaborates with scholars based in United States, Belgium and United Kingdom. Lutaf Islam's co-authors include Theodore A. Omachi, Claus Bachert, Philippe Gevaert, Kit Wong, Joaquim Mullol, Monet Howard, Monica Ligueros‐Saylan, Jonathan Corren, Joseph K. Han and Stella E. Lee and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Annals of Allergy Asthma & Immunology.

In The Last Decade

Lutaf Islam

10 papers receiving 564 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

2020 453 citations Philippe Gevaert, Theodore A. Omachi et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lutaf Islam United States	5	425	401	350	153	95	10	577
Lien Calus Belgium	8	582 1.4×	571 1.4×	516 1.5×	203 1.3×	121 1.3×	14	788
Aiko I. Klingler United States	8	388 0.9×	446 1.1×	373 1.1×	186 1.2×	60 0.6×	14	629
Sofia Necander Sweden	6	150 0.4×	140 0.3×	193 0.6×	71 0.5×	131 1.4×	18	334
Stuart Harlin United States	4	164 0.4×	164 0.4×	189 0.5×	115 0.8×	138 1.5×	6	353
Chien‐Chia Chuang United States	10	219 0.5×	162 0.4×	145 0.4×	49 0.3×	17 0.2×	25	335
S.M. Reinartz Netherlands	10	191 0.4×	82 0.2×	205 0.6×	82 0.5×	72 0.8×	19	348
Mariapina Battista Italy	7	125 0.3×	84 0.2×	96 0.3×	46 0.3×	43 0.5×	9	197
Gwijde Flavius Jacobus Petrus Maria Adriaensen Netherlands	7	59 0.1×	174 0.4×	45 0.1×	149 1.0×	15 0.2×	10	223
VJ Lund Australia	4	243 0.6×	52 0.1×	220 0.6×	100 0.7×	93 1.0×	5	360
Cindy K. Cook United States	10	427 1.0×	37 0.1×	403 1.2×	31 0.2×	108 1.1×	11	461

Countries citing papers authored by Lutaf Islam

Since Specialization

Citations

This map shows the geographic impact of Lutaf Islam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lutaf Islam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lutaf Islam more than expected).

Fields of papers citing papers by Lutaf Islam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lutaf Islam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lutaf Islam. The network helps show where Lutaf Islam may publish in the future.

Co-authorship network of co-authors of Lutaf Islam

This figure shows the co-authorship network connecting the top 25 collaborators of Lutaf Islam. A scholar is included among the top collaborators of Lutaf Islam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lutaf Islam. Lutaf Islam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Islam, Lutaf, et al.. (2023). Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps. World Allergy Organization Journal. 16(5). 100776–100776. 12 indexed citations

2.

Gevaert, Philippe, Jonathan Corren, Joseph K. Han, et al.. (2021). Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study. Journal of Allergy and Clinical Immunology. 149(3). 957–965.e3. 85 indexed citations

3.

Richeldi, Luca, Kevin J. Anstrom, Jürgen Behr, et al.. (2021). Recombinant human pentraxin-2 for idiopathic pulmonary fibrosis: Design of STARSCAPE-OLE, a Phase III open label extension study. PA461–PA461. 1 indexed citations

4.

Corren, Jonathan, Claus Bachert, Philippe Gevaert, et al.. (2020). Omalizumab Improves Quality of Life in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma. Journal of Allergy and Clinical Immunology. 145(2). AB250–AB250. 3 indexed citations

5.

Gevaert, Philippe, Peter W. Hellings, J. Mullol, et al.. (2020). Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis. Allergy. 75. 108–108. 1 indexed citations

6.

Gevaert, Philippe, Theodore A. Omachi, Jonathan Corren, et al.. (2020). Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. Journal of Allergy and Clinical Immunology. 146(3). 595–605. 453 indexed citations breakdown →

7.

Bachert, Claus, Philippe Gevaert, Jonathan Corren, et al.. (2020). Omalizumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps Irrespective of Asthma Status. Journal of Allergy and Clinical Immunology. 145(2). AB149–AB149. 4 indexed citations

8.

Gevaert, Philippe, J. Mullol, Rui Zhao, et al.. (2020). D202 CONTINUED SAFETY/EFFICACY OF OMALIZUMAB IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: AN OPEN-LABEL EXTENSION STUDY. Annals of Allergy Asthma & Immunology. 125(5). S15–S15. 5 indexed citations

9.

Gevaert, Philippe, Claus Bachert, J. Mullol, et al.. (2019). D450 OMALIZUMAB EFFICACY AND SAFETY IN NASAL POLYPOSIS: RESULTS FROM TWO PARALLEL, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS. Annals of Allergy Asthma & Immunology. 123(5). S17–S17. 11 indexed citations

10.

Islam, Lutaf, et al.. (2008). Evaluation of the Humoral Immune Response in Pulmonary Tuberculosis Patients. 1(2). 36–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact